Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
The Gene Expression of Ctrp12 But Not Ctrp13 Is Upregulated in Both Visceral and Subcutaneous Adipose Tissue of Obese Subjects Publisher Pubmed



Omidifar A1 ; Toolabi K2 ; Rahimipour A3, 4 ; Emamgholipour S5 ; Shanaki M3
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Medical Laboratory Sciences, School of Allied Medical Sciences, Student Research Committee, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  2. 2. Department of Surgery, Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Department of Medical Laboratory Sciences, School of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  4. 4. Department of Clinical Biochemistry, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  5. 5. Department of Clinical Biochemistry, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran

Source: Diabetes and Metabolic Syndrome: Clinical Research and Reviews Published:2019


Abstract

Obesity is a well-known chronic low-grade inflammation condition characterized by dysregulated adipokine secretion and function. Both CTRP12 and CTRP13 are adipokines that influence glucose and lipid metabolism. We aimed to investigate CTRP12, CTRP13, and inflammatory gene expressions in subcutaneous adipose tissue (SAT) and visceral adipose tissue (VAT) from obese women who underwent bariatric surgery in comparison with the normal weight women. This case-control study included 20 obese [body mass index (BMI) > 35–40 kg/m2] candidates for bariatric surgery and 20 normal-weight women (BMI <25 kg/m2) as control group, who underwent elective surgeries. Real-time PCR was used to evaluate mRNA expression levels of CTRP12, CTRP13, and inflammatory genes in SAT and VAT from both groups. We observed significantly higher mRNA expression of CTRP12 in SAT (p = 0.048) and VAT (p = 0.046) from obese patients compared to the controls. There was significantly greater expression of IL-6 and MCP-1 inflammatory genes in SAT (p = 0.013 and p = 0.005 respectively) and VAT (p = 0.000 and p = 0.001 respectively) of obese patients compared to the control group. IL-1β (p = 0.015) and TNF-α (p = 0.014) expressions significantly increased in VAT from obese patients compared to the control group. Spearman correlation analysis showed that CTRP12 expression significantly correlated with obesity indices. Our findings showed that CTRP12 significantly increased in both VAT and SAT of obese group. More importantly, we observed a positive correlation between CTRP12 with inflammatory parameters. These results indicated that CTRP12 might be part of an intricate network for glucose metabolism and obesity-related inflammation processes. © 2019
Related Docs
View other Related Docs
1. The C1q/Tnf-Related Proteins (Ctrps) in Pathogenesis of Obesity-Related Metabolic Disorders: Focus on Type 2 Diabetes and Cardiovascular Diseases, Life Sciences (2020)
2. Lower Circulating Levels of Ctrp12 and Ctrp13 in Polycystic Ovarian Syndrome: Irrespective of Obesity, PLoS ONE (2018)
3. Decreased Serum Levels of Ctrp12/Adipolin in Patients With Coronary Artery Disease in Relation to Inflammatory Cytokines and Insulin Resistance, Cytokine (2019)
4. Increased Mrna Expression of Ctrp3 and Ctrp9 in Adipose Tissue From Obese Women: Is It Linked to Obesity-Related Parameters and Mrna Expression of Inflammatory Cytokines?, Reports of Biochemistry and Molecular Biology (2020)
5. Association of C1q/Tnf-Related Protein-3 (Ctrp3) and Ctrp13 Serum Levels With Coronary Artery Disease in Subjects With and Without Type 2 Diabetes Mellitus, PLoS ONE (2016)
6. Association of Circulating Ctrp9 With Soluble Adhesion Molecules and Inflammatory Markers in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease, PLoS ONE (2018)
7. The Circulating Levels of Complement-Clq/Tnf-Related Protein 13 (Ctrp13) in Patients With Type 2 Diabetes and Its Association With Insulin Resistance, Clinical Laboratory (2017)
8. The Circulating Ctrp13 in Type 2 Diabetes and Non-Alcoholic Fatty Liver Patients, PLoS ONE (2016)
Experts (# of related papers)
View all Related Experts
Solaleh Emamgholipour (9)
Hossein Poustchi (4)
Other Related Docs
9. Role of Type 2 Diabetes and Hemodialysis in Serum Adipolin Concentrations: A Preliminary Study, Hemodialysis International (2019)
10. The Effect of Coenzyme Q10 Supplementation on Circulating Levels of Novel Adipokine Adipolin/Ctrp12 in Overweight and Obese Patients With Type 2 Diabetes, Experimental and Clinical Endocrinology and Diabetes (2017)
11. Circulating Levels of C1q/Tnf-Α‐Related Protein 6 (Ctrp6) in Coronary Artery Disease and Its Correlation With Inflammatory Markers, Journal of Diabetes and Metabolic Disorders (2024)
12. The Impacts of C1q/Tnf-Related Protein-15 and Adiponectin on Interleukin-6 and Tumor Necrosis Factor-Α in Primary Macrophages of Patients With Coronary Artery Diseases, Cytokine (2021)
13. The Circulating Levels of Ctrp1 and Ctrp5 Are Associated With Obesity Indices and Carotid Intima-Media Thickness (Cimt) Value in Patients With Type 2 Diabetes: A Preliminary Study, Diabetology and Metabolic Syndrome (2021)
14. Ctrp1 in Liver Disease, Advances in Clinical Chemistry (2017)
15. The Relationship Between Serum Adipokines and Glucose Homeostasis in Normal-Weight and Obese Patients on Hemodialysis: A Preliminary Study, International Urology and Nephrology (2020)
16. Serum C1q/Tnf-Related Protein-2 (Ctrp2) Levels Are Associated With Coronary Artery Disease, Archives of Medical Research (2020)
17. Lower Serum Levels of Meteorin-Like/Subfatin in Patients With Coronary Artery Disease and Type 2 Diabetes Mellitus Are Negatively Associated With Insulin Resistance and Inflammatory Cytokines, PLoS ONE (2018)
18. Evaluation of Changing the Pattern of Ctrp5 and Inflammatory Markers Levels in Patients With Coronary Artery Disease and Type 2 Diabetes Mellitus, Archives of Physiology and Biochemistry (2022)
19. Circulating Ctrp5 in Rheumatoid Arthritis: An Exploratory Biomarker Study, BMC Rheumatology (2022)
20. Fatty Acid Synthase and Acetyl-Coa Carboxylase Dysfunction in Visceral Adipose Tissue, Journal of Payavard Salamat (2020)
21. Lkb1: An Emerging Therapeutic Target for Cardiovascular Diseases, Life Sciences (2022)
22. C1q/Tnf-Related Protein-1: Potential Biomarker for Early Diagnosis of Autism Spectrum Disorder, International Journal of Immunopathology and Pharmacology (2022)
23. Plasma Complement C1q/Tumor Necrosis Factor-Related Protein 15 Concentration Is Associated With Polycystic Ovary Syndrome, PLoS ONE (2022)
24. The Effect of Metformin on Adipokines Levels: A Systematic Review and Meta-Analysis of Randomized-Controlled Trials, Diabetes Research and Clinical Practice (2024)
25. Serum Levels of Subfatin in Patients With Type 2 Diabetes Mellitus and Its Association With Vascular Adhesion Molecules, Archives of Physiology and Biochemistry (2020)
26. The Association of Circulating Levels of Complement-C1q Tnf-Related Protein 5 (Ctrp5) With Nonalcoholic Fatty Liver Disease and Type 2 Diabetes: A Case-Control Study, Diabetology and Metabolic Syndrome (2015)
27. Construction of an Exudative Age-Related Macular Degeneration Diagnostic and Therapeutic Molecular Network Using Multi-Layer Network Analysis, a Fuzzy Logic Model, and Deep Learning Techniques: Are Retinal and Brain Neurodegenerative Disorders Related?, Pharmaceuticals (2023)
28. Circulating Levels of C1q/Tnf-Α-Related Protein 6 (Ctrp6) in Polycystic Ovary Syndrome, IUBMB Life (2020)
29. Serum Levels of C1q/Tnf-Related Protein-3 in Inflammatory Bowel Disease Patients and Its Inverse Association With Inflammatory Cytokines and Insulin Resistance, IUBMB Life (2020)
30. Circulating Level of Ctrp1 in Patients With Nonalcoholic Fatty Liver Disease (Nafld): Is It Through Insulin Resistance?, PLoS ONE (2015)
31. Increased Circulating Level of Ctrp15 in Patients With Type 2 Diabetes Mellitus and Its Relation With Inflammation and Insulin Resistance, Journal of Diabetes and Metabolic Disorders (2021)
32. The Effects of 12 Weeks of Concurrent and Combined Training on Inflammatory Markers, Muscular Performance, and Body Composition in Middle-Aged Overweight and Obese Males, Nutrients (2023)